Net income decreased 25.8%
Net income changed -25.8% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income changed -25.8% from the comparable as-filed period.
Operating income changed -30.0% from the comparable as-filed period.
Operating margin changed -546 basis points from the comparable as-filed period.
Stock-based compensation changed +18.5% from the comparable as-filed period.
Gross margin changed -252 basis points from the comparable as-filed period.
Cash & equivalents changed -10.7% from the comparable as-filed period.
Inventory changed +8.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed +7.1% from the comparable as-filed period.
Revenue changed +10.6% from the comparable as-filed period.
Gross profit changed +4.4% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.